Gene · 8405
Papers2,215
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,215
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cellular cartography reveals mouse prostate organization and determinants of castration resistance. | Proc Natl Acad Sci U S A | 2025 | 40854129 | PubTator, text mining | PubMed |
| Biomolecular phase separation in tumorigenesis: from aberrant condensates to therapeutic vulnerabilities. | Mol Cancer | 2025 | 40849651 | PubTator, text mining | PubMed |
| The utility of next-generation sequencing in metastatic prostate cancer FNA biopsies. | Cancer Cytopathol | 2025 | 40847760 | PubTator, text mining | PubMed |
| Erratum: SPOP targets oncogenic protein ZBTB3 for destruction to suppress endometrial cancer. | Am J Cancer Res | 2025 | 40814367 | PubTator, text mining | PubMed |
| Enhanced NIR-II Nanoparticle Probe for PSMA-Targeted Molecular Imaging and Prostate Cancer Diagnosis. | Int J Nanomedicine | 2025 | 40808713 | PubTator, text mining | PubMed |
| The RNA helicase DDX17 enhances androgen receptor stability by interacting with the E3 ubiquitin ligase SPOP in prostate cancer. | Transl Androl Urol | 2025 | 40800095 | PubTator, text mining | PubMed |
| Challenges in the diagnosis of primary squamous cell carcinoma of the prostate: a case report and literature review. | Front Surg | 2025 | 40746833 | PubTator, text mining | PubMed |
| High-Grade Early-Onset Prostate Cancer: Assessment of TMPRSS2::ERG -Negative Tumors Suggests Low Frequency of Germline Alterations and a Pathogenic Role for HOXB13. | Am J Surg Pathol | 2025 | 40745946 | PubTator, text mining | PubMed |
Immune microenvironment heterogeneity characterizes biologically distinct KRASmut/SPOPmut and KRASmut/PIK3CAmut mesonephric-like adenocarcinoma subtypes revealed by integrated whole-exome and transcriptomic profiling. | Front Immunol | 2025 | 40740763 | PubTator, text mining | PubMed |
| Neural Stem Cell-Derived Extracellular Vesicles for Advanced Neural Repair. | J Neurochem | 2025 | 40734485 | PubTator, text mining | PubMed |
| The rheology and interfacial properties of biomolecular condensates. | Biophys Rev | 2025 | 40727669 | PubTator, text mining | PubMed |
| PINX1 inhibits proliferation and cisplatin resistance in nasopharyngeal carcinoma by promoting ILF3 ubiquitination. | Am J Cancer Res | 2025 | 40667563 | PubTator, text mining | PubMed |
| Deuterium labeling enables proteome-wide turnover kinetics analysis in cell culture. | Cell Rep Methods | 2025 | 40645189 | PubTator, text mining | PubMed |
| SPOP-dependent destabilization of SYT12 in a GSK-3β-dependent manner in papillary thyroid cancer cells. | Clin Exp Med | 2025 | 40640517 | PubTator, text mining | PubMed |
| Discovery of 2-Pyrazolylpyrimidinone Derivatives as New SPOP Inhibitors for Renal Cell Carcinoma Therapy. | J Med Chem | 2025 | 40622869 | PubTator, text mining | PubMed |
| Author Correction: The role of IGF2BP3/SPOP/c-Myc loop in paclitaxel resistance of endometrial cancer. | Commun Biol | 2025 | 40615653 | PubTator, text mining | PubMed |
| Erratum for the Research Article "ATM-phosphorylated SPOP contributes to 53BP1 exclusion from chromatin during DNA replication" by D. Wang et al. | Sci Adv | 2025 | 40577482 | PubTator, text mining | PubMed |
| Prognostic and immunological implications of cathepsin Z overexpression in prostate cancer. | Front Immunol | 2025 | 40568593 | PubTator, text mining | PubMed |
| Challenges and opportunities for the diverse substrates of SPOP E3 ubiquitin ligase in cancer. | Theranostics | 2025 | 40521202 | PubTator, text mining | PubMed |
| 'Intelligent' proteins. | Cell Mol Life Sci | 2025 | 40515853 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8405/papers?page=6